Cargando…
Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression
Apart from indolent systemic mastocytosis (SM), which is associated with a favorable prognosis, other subtypes of SM (SM with associated clonal hematologic non–mast cell lineage disease, aggressive SM, and mast cell leukemia – collectively referred to in this review as advanced SM) can be debilitati...
Autor principal: | Verstovsek, Srdan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3761194/ https://www.ncbi.nlm.nih.gov/pubmed/23181448 http://dx.doi.org/10.1111/ejh.12043 |
Ejemplares similares
-
Systemic Mastocytosis and Other Entities Involving Mast Cells: A Practical Review and Update
por: El Hussein, Siba, et al.
Publicado: (2022) -
Response Criteria in Advanced Systemic Mastocytosis: Evolution in the Era of KIT Inhibitors
por: Shomali, William, et al.
Publicado: (2021) -
Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder
por: Chatterjee, Anindya, et al.
Publicado: (2015) -
Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
por: Ke, Hengning, et al.
Publicado: (2016) -
A case of lymphocytic variant hypereosinophilic syndrome with sub-diagnostic systemic mastocytosis
por: Jain, Preetesh, et al.
Publicado: (2017)